Symbol="VRCA"
AssetType="Common Stock"
Name="Verrica Pharmaceuticals Inc"
Description="Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania."
CIK="1660334"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10 NORTH HIGH STREET, SUITE 200, WEST CHESTER, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="300498000"
EBITDA="-20488000"
PERatio="None"
PEGRatio="None"
BookValue="1.549"
DividendPerShare="0"
DividendYield="0"
EPS="-0.57"
RevenuePerShareTTM="0.227"
ProfitMargin="-2.617"
OperatingMarginTTM="-2.428"
ReturnOnAssetsTTM="-0.187"
ReturnOnEquityTTM="-0.501"
RevenueTTM="8638000"
GrossProfitTTM="8307000"
DilutedEPSTTM="-0.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.914"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="14.39"
PriceToBookRatio="2.827"
EVToRevenue="9.9"
EVToEBITDA="-3.676"
Beta="1.991"
num_52WeekHigh="8.7"
num_52WeekLow="2.02"
num_50DayMovingAverage="6.11"
num_200DayMovingAverage="5.03"
SharesOutstanding="41852100"
DividendDate="None"
ExDividendDate="None"
symbol="VRCA"
open="7.10"
high="7.24"
low="7.00"
price="7.18"
volume="528424.00"
latest_trading_day="2023-07-20"
previous_close="7.08"
change="0.10"
change_percent="1.4124%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="206186"
Change_recent_avg="-0.03"
Delta_recent_avg="0.4"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="-0.51"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_negative_thumbnail_id_2="492"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="984"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_positive_thumbnail_id_2="1008"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0170.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
